Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Edwards Lifesciences Corp Transaction History

Mitsubishi Ufj Morgan Stanley Securities Co., Ltd.

$7.89 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$68.3 - $87.44 $2,732 - $3,497	-40 Reduced 50.0%	40 $3,000
Q1 2022 May 04, 2022	SELL	$101.96 - $128.34 $27,529 - $34,651	-270 Reduced 77.14%	80 $9,000
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $37,229 - $45,738	-350 Reduced 50.0%	350 $45,000
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $72,037 - $85,925	700 New	700 $79,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.

Account